Lacassagne L, Didier A, Doussau S, Murris-Espin M, Birot P, Charlet J P, Thach K S, Tiberge M, Paoli J R, Pessey J J, Léophonte P
Service de Pneumologie et Allergologie, CHR Rangueil, Toulouse.
Rev Mal Respir. 2000 Apr;17(2):467-74.
Between 1990 and 1995, 369 patients were investigated for obstructive sleep apnea syndrome (OSAS) by polysomnography. Among them, 248 patients with a mean Apnea-Hyponea index (AHI) of 37.7 per hour were treated by nasal continuous positive airway pressure (n-CPAP). Mean follow up was 39.5 +/- 20.4 months. In this group, 23 patients (9.2%) refused nCPAP immediately or after the first night and 39 (15.7%) gave up later. 15 patients (6%) died during the period of the study. The cumulative compliance reached 70% at 72 months. Non compliant patients usually gave up n-CPAP before the end of the first year. We compared the group of 150 patients always treated at the date of 31/12/95 with the group of 62 patients who refused nCPAP initially or gave up later. There was no difference in clinical parameters or polysomnographic data between the two groups. In 94 patients treated by nCPAP for more than a year we evaluated the outcome of AHI by a polysomnography performed after 72 hours of nCPAP cessation. Mean AHI of the group at this time was 38.2 +/- 20.3/h and was well correlated with the initial index (r = 0.41, p < 0.0001). However for 28 patients (29.7%) we observed, at the time of this second AHI determination, a variation (plus or minus) of at least 50% of the index. 6 patients, without any significative weigth loss, had an AHI below 5/h at this second determination. In this small group nCPAP was interrupted for 6 to 12 months, then another polysomnography was performed. At this time mean AHI was 42.4/h and clinical symptoms had reappeared in all patients. This study demonstrated that compliance to nCPAP in OSAS patients is good. No clinical or polysomnographic factors allow to predict non compliance. AHI is not modified by long term treatment with nCPAP.
1990年至1995年间,对369例患者进行了多导睡眠图检查以诊断阻塞性睡眠呼吸暂停综合征(OSAS)。其中,248例平均呼吸暂停低通气指数(AHI)为每小时37.7次的患者接受了经鼻持续气道正压通气(n-CPAP)治疗。平均随访时间为39.5±20.4个月。在该组中,23例患者(9.2%)在首次使用n-CPAP时或第一晚后立即拒绝使用,39例患者(15.7%)后来放弃使用。15例患者(6%)在研究期间死亡。72个月时累积依从率达到70%。不依从的患者通常在第一年末之前就放弃了n-CPAP。我们将1995年12月31日时一直接受治疗的150例患者组与最初拒绝或后来放弃n-CPAP的62例患者组进行了比较。两组之间的临床参数或多导睡眠图数据没有差异。在94例接受n-CPAP治疗超过一年的患者中,我们在停止n-CPAP 72小时后通过多导睡眠图评估了AHI的结果。此时该组的平均AHI为38.2±20.3次/小时,与初始指数密切相关(r = 0.41,p < 0.0001)。然而,在第二次AHI测定时,我们观察到28例患者(29.7%)的指数变化(增加或减少)至少50%。6例患者在第二次测定时体重没有明显减轻,但AHI低于5次/小时。在这个小群体中,n-CPAP中断了6至12个月,然后进行了另一次多导睡眠图检查。此时平均AHI为42.4次/小时,所有患者的临床症状都再次出现。这项研究表明,OSAS患者对n-CPAP的依从性良好。没有临床或多导睡眠图因素可以预测不依从情况。长期使用n-CPAP不会改变AHI。